Gradient Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-9
| Closed | -$1.24K | – | 771 |
|
|
2024
Q2 | $1.24K | Sell |
9
-1
| -10% | -$133 | ﹤0.01% | 1050 |
|
|
2024
Q1 | $1.36K | Sell |
10
-41
| -80% | -$5.6K | ﹤0.01% | 873 |
|
|
2023
Q4 | $6.92K | Sell |
51
-30
| -37% | -$3.66K | ﹤0.01% | 909 |
|
|
2023
Q3 | $9.9K | Sell |
81
-352
| -81% | -$44.8K | ﹤0.01% | 813 |
|
|
2023
Q2 | $54.9K | Sell |
433
-418
| -49% | -$54.3K | ﹤0.01% | 486 |
|
|
2023
Q1 | $110K | Sell |
851
-270,609
| -100% | -$35.4M | ﹤0.01% | 362 |
|
|
2022
Q4 | $35.6M | Sell |
271,460
-2,780
| -1% | -$359K | 1.12% | 20 |
|
|
2022
Q3 | $32.1M | Buy |
274,240
+274,034
| +133,026% | +$34M | 0.98% | 22 |
|
|
2022
Q2 | $24K | Buy |
206
+5
| +2% | +$594 | ﹤0.01% | 613 |
|
|
2022
Q1 | $26K | Hold |
201
| – | – | ﹤0.01% | 599 |
|
|
2021
Q4 | $31K | Buy |
201
+100
| +99% | +$15.5K | ﹤0.01% | 576 |
|
|
2021
Q3 | $16K | Buy |
+101
| New | +$17K | ﹤0.01% | 683 |
|
|
2020
Q3 | – | Sell |
-25
| Closed | -$3K | – | 1173 |
|
|
2020
Q2 | $3K | Sell |
25
-1
| -4% | -$127 | ﹤0.01% | 831 |
|
|
2020
Q1 | $3K | Buy |
26
+1
| +4% | +$115 | ﹤0.01% | 853 |
|
|
2019
Q4 | $3K | Sell |
25
-102
| -80% | -$11.4K | ﹤0.01% | 892 |
|
|
2019
Q3 | $13K | Buy |
127
+75
| +144% | +$7.85K | ﹤0.01% | 607 |
|
|
2019
Q2 | $6K | Buy |
52
+27
| +108% | +$2.87K | ﹤0.01% | 744 |
|
|
2019
Q1 | $3K | Hold |
25
| – | – | ﹤0.01% | 706 |
|
|
2018
Q4 | $2K | Sell |
25
-301
| -92% | -$31.9K | ﹤0.01% | 822 |
|
|
2018
Q3 | $37K | Buy |
326
+70
| +27% | +$8.24K | ﹤0.01% | 402 |
|
|
2018
Q2 | $28K | Buy |
256
+79
| +45% | +$8.45K | ﹤0.01% | 427 |
|
|
2018
Q1 | $19K | Buy |
177
+120
| +211% | +$13.3K | ﹤0.01% | 481 |
|
|
2017
Q4 | $6K | Buy |
+57
| New | +$6.09K | ﹤0.01% | 667 |
|
|
2017
Q3 | – | Sell |
-57
| Closed | -$6K | – | 446 |
|
|
2017
Q2 | $6K | Sell |
57
-153
| -73% | -$15.1K | ﹤0.01% | 555 |
|
|
2017
Q1 | $21K | Buy |
210
+3
| +1% | +$287 | ﹤0.01% | 392 |
|
|
2016
Q4 | $18K | Buy |
+207
| New | +$18.8K | ﹤0.01% | 367 |
|
|
2016
Q1 | – | Sell |
-1,545
| Closed | -$174K | – | 756 |
|
|
2015
Q4 | $174K | Buy |
+1,545
| New | +$168K | 0.02% | 179 |
|
|
2015
Q3 | – | Sell |
-6
| Closed | -$1K | – | 642 |
|
|
2015
Q2 | $1K | Buy |
+6
| New | +$718 | ﹤0.01% | 572 |
|
Other funds holding IBB
CB
Gradient Investments's IBB Position: Q3 2024 in Review
Gradient Investments sold out of iShares Biotechnology ETF (IBB) in Q3 2024, closing a stake of 9 shares — an estimated $1.24K sold.
Gradient Investments first reported a position in IBB in Q2 2015 and held it in 28 quarters. The position peaked at $35.6M in Q4 2022. 893 funds tracked by Wall St. Rank hold IBB as of Q3 2024.
- Gradient Investments reported no remaining iShares Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
- Gradient Investments sold 9 iShares Biotechnology ETF shares in Q3 2024, an estimated $1.24K.
- Gradient Investments first reported a position in iShares Biotechnology ETF in Q2 2015 and held it in 28 quarters.
- Gradient Investments's iShares Biotechnology ETF position peaked at $35.6M in Q4 2022.
- 893 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2024.
Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.